DEVELOPMENT AND EVALUATION OF ITRACONAZOLE SOLID DISPERSION GEL CUTANEOUS DELIVERY

Authors

  • NIMMATHOTA MADHAVI Department of Pharmaceutics, CMR College of Pharmacy, Affiliated to JNTUH, Hyderabad, and Telangana-501401, India https://orcid.org/0000-0002-0458-7406
  • BEERAVELLI SUDHAKAR Department of Pharmaceutical Technology, A U College of Pharmaceutical Sciences, Andhra University, Visakhapatnam-530003, India
  • UPPALAPU SRAVANI Department of Pharmaceutical Technology, A U College of Pharmaceutical Sciences, Andhra University, Visakhapatnam-530003, India https://orcid.org/0000-0002-0458-7406

DOI:

https://doi.org/10.22159/ijap.2023v15i6.48978

Keywords:

Permeation, Dissolution, Kneading, Physical mixture, Solid dispersion

Abstract

Objective: The objective of this research is to enhance the permeation of low bioavailable drugs with suitable dosage forms by utilizing various permeation enhancers.

Methods: Solid dispersions (SDs) were prepared by kneading, whereas physical mixtures (PM) were prepared by simple mixing with polymers PEG 6000 and PEG 20000 and evaluated for various physicochemical parameters. Optimized SDs were converted to gels using a variety of polymers and were evaluated for in vitro and ex vivo permeation studies.

Results: It was found that the percentage of drugs in SDs and PMs was within the limit. The dissolution of SDs and PMs was found to be the highest with PEG-6000 (99.78% within 240 min) compared to PEG 20000. The maximum drug release (92.9% within 8 h) was achieved with oleic acid in both in vitro and ex vivo permeation studies, as evidenced by the in vitro and ex vivo permeation studies. The developed formulations showed no incompatibility between drugs and excipients, as demonstrated by drug and excipient interaction studies.

Conclusion: The results that were observed confirmed that the itraconazole PEG-6000 gel developed has promising effects on desirable skin permeation.

Downloads

Download data is not yet available.

References

Sardana K, Mathachan SR. Super bioavailable itraconazole and its place and relevance in recalcitrant dermatophytosis: revisiting skin levels of itraconazole and minimum inhibitory concentration data. Indian Dermatol Online J. 2021 Jan;12(1):1-5. doi: 10.4103/idoj.IDOJ_618_20, PMID 33768016.

Dominguez Gil Hurle A, Sanchez Navarro A, Garcia Sanchez MJ. Therapeutic drug monitoring of itraconazole and the relevance of pharmacokinetic interactions. Clin Microbiol Infect. 2006;12(7):97-106. ISSN 1198-743X. doi: 10.1111/j.1469-0691.2006.01611.x.

Barone JA, Moskovitz BL, Guarnieri J, Hassell AE, Colaizzi JL, Bierman RH. Enhanced bioavailability of itraconazole in hydroxypropyl-beta-cyclodextrin solution versus capsules in healthy volunteers. Antimicrob Agents Chemother. 1998 Jul;42(7):1862-5. doi: 10.1128/AAC.42.7.1862, PMID 9661037.

Lee JH, Park C, Weon KY, Kang CY, Lee BJ, Park JB. Improved bioavailability of poorly water-soluble drugs by targeting increased absorption through solubility enhancement and precipitation inhibition. Pharmaceuticals (Basel). 2021;14(12):1255. doi: 10.3390/ph14121255, PMID 34959655.

Marichal P, Gorrens J, Vanden Bossche H. The action of itraconazole and ketoconazole on growth and sterol synthesis in aspergillus fumigatus and Aspergillus niger. Sabouraudia. 1985 Feb;23(1):13-21. doi: 10.1080/00362178585380041, PMID 2986303.

Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. ISRN Pharm. 2012;2012:195727. doi: 10.5402/2012/195727, PMID 22830056.

Vandana KR, Prasanna Raju Y, Harini Chowdary V, Sushma M, Vijay Kumar N. An overview on in situ micronization technique–an emerging novel concept in advanced drug delivery. Saudi Pharm J. 2014 Sep;22(4):283-9. doi: 10.1016/j.jsps.2013.05.004, PMID 25161371.

Jagtap VA, Vidyasagar G, Dvivedi SC. Solubility enhancement of rosiglitazone by using melt sonocrystallization technique. J Ultrasound. 2014 Feb 27;17(1):27-32. doi: 10.1007/s40477-014-0074-9, PMID 24616749.

Loftsson T. Drug solubilization by complexation. Int J Pharm. 2017 Oct 5;531(1):276-80. doi: 10.1016/j.ijpharm.2017.08.087, PMID 28842309.

Serajuddin AT. Salt formation to improve drug solubility. Adv Drug Deliv Rev. 2007 Jul 30;59(7):603-16. doi: 10.1016/j.addr.2007.05.010, PMID 17619064.

Bolourchian N, Mahboobian MM, Dadashzadeh S. The effect of PEG molecular weights on dissolution behavior of simvastatin in solid dispersions. Iran J Pharm Res. 2013;Suppl 12:11-20. PMID 24250667.

Biswal S, Sahoo J, Murthy PN, Giradkar RP, Avari JG. Enhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000. AAPS PharmSciTech. 2008;9(2):563-70. doi: 10.1208/s12249-008-9079-z, PMID 18459056.

Alshamrani M, Khan MK, Khan BA, Salawi A, Almoshari Y. Technologies for solubility, dissolution and permeation enhancement of natural compounds. Pharmaceuticals (Basel). 2022 May 25;15(6):653. doi: 10.3390/ph15060653, PMID 35745572.

Ghareeb MM, Abdulrasool AA, Hussein AA, Noordin MI. Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188. AAPS PharmSciTech. 2009;10(4):1206-15. doi: 10.1208/s12249-009-9316-0, PMID 19862626.

Tekade AR, Yadav JN. A review on solid dispersion and carriers used therein for solubility enhancement of poorly water-soluble drugs. Adv Pharm Bull. 2020 Jul;10(3):359-69. doi: 10.34172/apb.2020.044, PMID 32665894.

Benavent C, Torrado Salmeron C, Torrado Santiago S. Development of a solid dispersion of nystatin with maltodextrin as a carrier agent: improvements in antifungal efficacy against Candida spp. biofilm infections. Pharmaceuticals (Basel). 2021;14(5):397. doi: 10.3390/ph14050397, PMID 33922089.

Subair TK, Mohanan J. Development of nano-based film-forming gel for prolonged dermal delivery of luliconazole. Int J Pharm Pharm Sci. 2022;14(2):31-41. doi: 10.22159/ijpps.2022v14i2.43253.

Saritha A, Surendran OG, Vinaya. Formulation and evaluation of clotrimazole solid dispersion incorporated gels. Int J PharmTech Res. 2013;5(3):1345-54.

Singh S, Sharma N, Kaur G. Central composite designed solid dispersion for dissolution enhancement of fluvastatin sodium by kneading technique. Ther Deliv. 2020 May;11(5):313-28. doi: 10.4155/tde-2020-0025, PMID 32486926.

Modi A, Tayade P. Enhancement of dissolution profile by solid dispersion (kneading) technique. AAPS PharmSciTech. 2006 Aug 18;7(3):68. doi: 10.1208/pt070368, PMID 17025249.

Yin X, Daintree LS, Ding S, Ledger DM, Wang B, Zhao W. Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs. Drug Des Devel Ther. 2015;9:2801-10. doi: 10.2147/DDDT.S81253, PMID 26060397.

Jung JY, Yoo SD, Lee SH, Kim KH, Yoon DS, Lee KH. Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique. Int J Pharm. 1999 Oct 5;187(2):209-18. doi: 10.1016/s0378-5173(99)00191-x, PMID 10502627.

Soliman SM, Abdel Malak NS, El Gazayerly ON, Abdel Rehim AA. Preparation of celecoxib solid dispersions for dermal application: in vitro characterization and skin irritation test. J Drug Deliv Sci Technol. 2011;21(6):509-16. doi: 10.1016/S1773-2247(11)50082-6.

Alaayedi M, Mahmood H, Saeed A. The enhancement effect of castor oil on the permeability of flurbiprofen as a transdermal gel. Int J App Pharm. 2018 Jan 7;10(1):140-4. doi: 10.22159/ijap.2018v10i1.23348.

Jiang SJ, Zhou XJ. Examination of the mechanism of oleic acid-induced percutaneous penetration enhancement: an ultrastructural study. Biol Pharm Bull. 2003 Jan;26(1):66-8. doi: 10.1248/bpb.26.66, PMID 12520175.

Published

07-11-2023

How to Cite

MADHAVI, N., SUDHAKAR, B., & SRAVANI, U. (2023). DEVELOPMENT AND EVALUATION OF ITRACONAZOLE SOLID DISPERSION GEL CUTANEOUS DELIVERY. International Journal of Applied Pharmaceutics, 15(6), 334–341. https://doi.org/10.22159/ijap.2023v15i6.48978

Issue

Section

Original Article(s)